DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
CYTOSINE
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma
Unknown
CYTOSINE
×
Maximum Phase:
2
First Approval:
None
UNII:
8J337D1HZY
Molecule Type:
Small molecule
Molecular Formula:
C4H5N3O
Molecular Weight:
111.1
AlogP:
-0.65
PSA:
71.77
HBD:
2.0
HBA:
#RotB:
0.0
Source:
WHEAT GERM OIL
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
WHEAT GERM OIL
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PCI-27483
2
Small molecule
Investigational
Unknown
Unknown
Pancreatic Neoplasms
Coagulation factor VII inhibitor
PCI-27483
×
Maximum Phase:
2
First Approval:
None
UNII:
6073LCU8U9
Molecule Type:
Small molecule
Molecular Formula:
C26H24N6O9S
Molecular Weight:
596.58
AlogP:
0.83
PSA:
282.87
HBD:
9.0
HBA:
#RotB:
10.0
Source:
APADAMTASE ALFA
2
Enzyme
Investigational
Unknown
Unknown
Anemia, Sickle Cell; Purpura, Thrombotic Thrombocytopenic
Unknown
APADAMTASE ALFA
×
Maximum Phase:
2
First Approval:
None
UNII:
U5SFU33XUX
Molecule Type:
Enzyme
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CARBAPENEM
2
Small molecule
Investigational
Unknown
Unknown
Infections
Unknown
CARBAPENEM
×
Maximum Phase:
2
First Approval:
None
UNII:
GL970841YS
Molecule Type:
Small molecule
Molecular Formula:
C7H7NO3
Molecular Weight:
153.14
AlogP:
-0.04
PSA:
57.61
HBD:
1.0
HBA:
#RotB:
1.0
Source:
ETHYL PYRUVATE
2
Small molecule
Investigational
Unknown
Unknown
Coronary Disease
Unknown
ETHYL PYRUVATE
×
Maximum Phase:
2
First Approval:
None
UNII:
03O98E01OB
Molecule Type:
Small molecule
Molecular Formula:
C5H8O3
Molecular Weight:
116.12
AlogP:
0.14
PSA:
43.37
HBD:
0.0
HBA:
#RotB:
2.0
Source:
ABRILUMAB
2
Antibody
Investigational
Unknown
Unknown
Colitis, Ulcerative; Crohn Disease
Integrin alpha-4/beta-7 inhibitor
ABRILUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
Y9UQ37XT2T
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FOSBRETABULIN
2
Small molecule
Investigational
Unknown
Unknown
Ovarian Neoplasms; Neoplasms; Neuroendocrine Tumors; Thyroid Neoplasms
Unknown
FOSBRETABULIN
×
Maximum Phase:
2
First Approval:
None
UNII:
I5590ES2QZ
Molecule Type:
Small molecule
Molecular Formula:
C18H21O8P
Molecular Weight:
396.33
AlogP:
3.36
PSA:
103.68
HBD:
2.0
HBA:
#RotB:
8.0
Source:
BELCESIRAN
2
Oligonucleotide
Investigational
Unknown
Unknown
alpha 1-Antitrypsin Deficiency
Unknown
BELCESIRAN
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Oligonucleotide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TNP-2092
2
Small molecule
Investigational
Unknown
Unknown
Infections; Gram-Positive Bacterial Infections
Bacterial DNA-directed RNA polymerase inhibitor
TNP-2092
×
Maximum Phase:
2
First Approval:
None
UNII:
W2P7EF7O6O
Molecule Type:
Small molecule
Molecular Formula:
C65H81FN6O15
Molecular Weight:
1205.39
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
CAPSICUM OLEORESIN
2
Unknown
Investigational
Unknown
Unknown
Cough
Unknown
CAPSICUM OLEORESIN
×
Maximum Phase:
2
First Approval:
None
UNII:
UW86K581WY
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SELK2
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
SELK2
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NELOTANSERIN
2
Small molecule
Investigational
Unknown
Unknown
Hallucinations; Lewy Body Disease; Sleep Initiation and Maintenance Disorders
Serotonin 2a (5-HT2a) receptor inverse agonist
NELOTANSERIN
×
Maximum Phase:
2
First Approval:
None
UNII:
4ZA73QEW2P
Molecule Type:
Small molecule
Molecular Formula:
C18H15BrF2N4O2
Molecular Weight:
437.24
AlogP:
4.78
PSA:
68.18
HBD:
2.0
HBA:
#RotB:
4.0
Source:
TG100-801
2
Small molecule
Investigational
Unknown
Unknown
Diabetic Retinopathy; Macular Degeneration; Wet Macular Degeneration
Ephrin type-B receptor 4 inhibitor
TG100-801
×
Maximum Phase:
2
First Approval:
None
UNII:
1VZO7A0J9S
Molecule Type:
Small molecule
Molecular Formula:
C33H30ClN5O3
Molecular Weight:
580.09
AlogP:
7.09
PSA:
89.47
HBD:
1.0
HBA:
#RotB:
9.0
Source:
SAR-103168
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
SAR-103168
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
REGDANVIMAB
2
Antibody
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Unknown
REGDANVIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TALETRECTINIB
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Unknown
TALETRECTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C23H24FN5O
Molecular Weight:
405.48
AlogP:
4.43
PSA:
77.47
HBD:
2.0
HBA:
#RotB:
7.0
Source:
AZD-4017
2
Small molecule
Investigational
Unknown
Unknown
Obesity; Diabetes Mellitus, Type 2; Ocular Hypertension; Pituitary ACTH Hypersecretion; Pseudotumor Cerebri
11-beta-hydroxysteroid dehydrogenase 1 inhibitor
AZD-4017
×
Maximum Phase:
2
First Approval:
None
UNII:
3JL137394Y
Molecule Type:
Small molecule
Molecular Formula:
C22H33N3O3S
Molecular Weight:
419.59
AlogP:
4.34
PSA:
82.53
HBD:
2.0
HBA:
#RotB:
8.0
Source:
PHOSPHORYLETHANOLAMINE
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
PHOSPHORYLETHANOLAMINE
×
Maximum Phase:
2
First Approval:
None
UNII:
78A2BX7AEU
Molecule Type:
Small molecule
Molecular Formula:
C2H8NO4P
Molecular Weight:
141.06
AlogP:
-0.95
PSA:
92.78
HBD:
3.0
HBA:
#RotB:
3.0
Source:
CAVOSONSTAT
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Cystic Fibrosis; Pulmonary Disease, Chronic Obstructive
Alcohol dehydrogenase class III inhibitor
CAVOSONSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
O2Z8Q22ZE4
Molecule Type:
Small molecule
Molecular Formula:
C16H10ClNO3
Molecular Weight:
299.71
AlogP:
3.96
PSA:
70.42
HBD:
2.0
HBA:
#RotB:
2.0
Source:
FISETIN
2
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis, Knee; Neoplasms; Severe Acute Respiratory Syndrome
Unknown
FISETIN
×
Maximum Phase:
2
First Approval:
None
UNII:
OO2ABO9578
Molecule Type:
Small molecule
Molecular Formula:
C15H10O6
Molecular Weight:
286.24
AlogP:
2.28
PSA:
111.13
HBD:
4.0
HBA:
#RotB:
1.0
Source:
MODOTUXIMAB
2
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
MODOTUXIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
1W7BD1M08N
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DROZITUMAB
2
Antibody
Investigational
Unknown
Unknown
Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Chondrosarcoma; Lymphoma, Non-Hodgkin
Tumor necrosis factor receptor superfamily member 10B agonist
DROZITUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
SQ67484MA7
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OSI-7904
2
Small molecule
Investigational
Unknown
Unknown
Colorectal Neoplasms; Neoplasms; Head and Neck Neoplasms
Thymidylate synthase inhibitor
OSI-7904
×
Maximum Phase:
2
First Approval:
None
UNII:
ON177ZCE7M
Molecule Type:
Small molecule
Molecular Formula:
C27H24N4O6
Molecular Weight:
500.51
AlogP:
3.27
PSA:
152.69
HBD:
4.0
HBA:
#RotB:
8.0
Source:
131I-RITUXIMAB
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
131I-RITUXIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
GSK163090
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major; Depressive Disorder
Serotonin 1a (5-HT1a) receptor antagonist
GSK163090
×
Maximum Phase:
2
First Approval:
None
UNII:
7XI927X82B
Molecule Type:
Small molecule
Molecular Formula:
C25H29N5O
Molecular Weight:
415.54
AlogP:
3.44
PSA:
51.71
HBD:
1.0
HBA:
#RotB:
5.0
Source:
IOWH-032
2
Small molecule
Investigational
Unknown
Unknown
Digestive System Diseases
Unknown
IOWH-032
×
Maximum Phase:
2
First Approval:
None
UNII:
8Y3GDT6YWV
Molecule Type:
Small molecule
Molecular Formula:
C22H15Br2N3O4
Molecular Weight:
545.19
AlogP:
5.69
PSA:
97.48
HBD:
2.0
HBA:
#RotB:
6.0
Source:
VOTUCALIS
2
Protein
Investigational
Unknown
Unknown
Rhinitis, Allergic, Seasonal; Inflammation
Unknown
VOTUCALIS
×
Maximum Phase:
2
First Approval:
None
UNII:
V94JSH9V48
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SARCOSINE
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major; Schizophrenia
Unknown
SARCOSINE
×
Maximum Phase:
2
First Approval:
None
UNII:
Z711V88R5F
Molecule Type:
Small molecule
Molecular Formula:
C3H7NO2
Molecular Weight:
89.09
AlogP:
-0.71
PSA:
49.33
HBD:
2.0
HBA:
#RotB:
2.0
Source:
BIMIRALISIB
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Neoplasms; Glioblastoma; Lymphoma; Lymphoma, Non-Hodgkin
Unknown
BIMIRALISIB
×
Maximum Phase:
2
First Approval:
None
UNII:
6Z3QHB00LB
Molecule Type:
Small molecule
Molecular Formula:
C17H20F3N7O2
Molecular Weight:
411.39
AlogP:
1.21
PSA:
102.52
HBD:
1.0
HBA:
#RotB:
3.0
Source:
CAVATAK
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
CAVATAK
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FEZAKINUMAB
2
Antibody
Investigational
Unknown
Unknown
Psoriasis; Arthritis, Rheumatoid; Dermatitis, Atopic
Interleukin-22 inhibitor
FEZAKINUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
0S77U25XZ3
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RINFABATE
2
Unknown
Investigational
Unknown
Unknown
Noonan Syndrome; Retinopathy of Prematurity
Unknown
RINFABATE
×
Maximum Phase:
2
First Approval:
None
UNII:
KU1MBT4JJB
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CARPERITIDE
2
Protein
Investigational
Unknown
Unknown
Unknown
Atrial natriuretic peptide receptor agonist
CARPERITIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
GZ8FA500J0
Molecule Type:
Protein
Molecular Formula:
C127H203N45O39S3
Molecular Weight:
3080.5
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ENMD-981693
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Neoplasms; Breast Neoplasms; Colorectal Neoplasms; Pancreatic Neoplasms
Fibroblast growth factor receptor inhibitor
ENMD-981693
×
Maximum Phase:
2
First Approval:
None
UNII:
DNZ11VPY7Q
Molecule Type:
Small molecule
Molecular Formula:
C22H16N4O4
Molecular Weight:
400.39
AlogP:
3.15
PSA:
99.17
HBD:
1.0
HBA:
#RotB:
3.0
Source:
1
2
…
136
137
138
139
140
141
142
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA